ReviewESMO real world data and digital oncology2026
From rejection to formative development: recalibrating decisions for under-resourced authors.
Review in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peer review and editorial triage together are the cornerstones of scientific credibility yet their combined cracks are increasingly visible. As real-world data and digital health technologies have become increasingly important sources of evidence generation, many promising submissions from under-resourced settings receive terse desk rejections or nonspecialist reviews that obscure remediable methodological and reporting issues, limiting learning and career progression. We propose a compact, author-initiated, equity-centred remediation pathway-the mentorship escrow-that integrates upstream supports, a core remediation window, and a downstream pathway, converting borderline submissions into time-bounded and capacity-building interventions. We outline practical implementation steps, pilot design considerations, and measurable equity and quality metrics; discuss trade-offs across components; and address variable constraints including mentor availability, funding, potential selection bias, and risks of dependency, proposing mitigation strategies to ensure scalable, sustainable capacity building that preserves editorial standards while broadening the circulation of locally relevant evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.